Various health-related effects of long-chain (LC) omega-3 polyunsaturated fatty acids
(PUFAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have been …

The recent publication of the REDUCE-IT study has reopened the debate about the efficacy
of omega-3 fatty acids in reducing the risk of cardiovascular (CV) events. This meta-analysis …

Lower incidence of cardiovascular disease (CVD) in the Greenland Inuit, Northern Canada
and Japan has been attributed to their consumption of seafood rich in long chain omega-3 …

Fish oil is rich in the omega-3 polyunsaturated fatty acids (PUFAs) eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA). Numerous epidemiological studies and several …

There has been a great deal of controversy in recent years about the potential role of dietary
supplementation with long-chain omega-3 polyunsaturated fatty acids (n-3 PUFA) in the …

Introduction: An epidemiological study of Greenlandic Inuit suggested the importance of
omega-3 polyunsaturated fatty acids (PUFAs) in preventing ischemic heart disease. After …

Opinion statement Early secondary prevention trials of fish and omega-3 polyunsaturated
fatty acid (PUFA) capsules reported beneficial effects on cardiovascular disease (CVD) …

Abstract The 2015 Dietary Guidelines for Americans recommend limiting the intake of
saturated fatty acids (SFAs) to< 10% of energy/d and replacing dietary SFAs with …

Omega-3 polyunsaturated fatty acid (ω-3 PUFA) therapy continues to show great promise in
primary and, particularly in secondary prevention of cardiovascular (CV) diseases. The most …

A large body of evidence supports the cardioprotective effects of the long-chain omega-3
polyunsaturated fatty acids (PUFAs), eicosapentaenoic acid (EPA), and docosahexaenoic …